Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Training Bioreactor Operators – V 2.0

Posted on By


Biosimilars: SOP for Training Bioreactor Operators – V 2.0

/>

Standard Operating Procedure for Training Bioreactor Operators in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/119/2025
Supersedes SOP/BS/119/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a structured and standardized training procedure for bioreactor operators involved in biosimilar upstream processing to ensure competency, regulatory compliance, and consistent operational performance.

2. Scope

This SOP applies to all new and existing operators assigned to bioreactor setup, operation, monitoring, sampling, and shutdown tasks in biosimilar production facilities.

3. Responsibilities

  • Training Coordinator: Schedule, conduct, and document training activities.
  • Department Head: Nominate trainees and ensure their timely qualification.
  • QA: Review training records and approve final qualification status.
See also  Biosimilars: SOP for Concentration Adjustment Post-UF - V 2.0

4. Accountability

The Head of Manufacturing is accountable for maintaining a fully trained and qualified pool of bioreactor operators aligned with GMP and safety guidelines.

5. Procedure

5.1 Induction Training

  1. All new hires must undergo induction covering:
    • Company policies and SOP compliance
    • Basic GMP principles and cleanroom behavior
    • Personal hygiene and gowning

5.2 Technical Training Modules

  1. Conduct theory and practical sessions covering:
    • Bioreactor parts and functions
    • Sterile connections and SIP procedures
    • pH, DO, and agitation control
    • Batch documentation and log entries
    • Inoculation, feeding, and sampling techniques
  2. Trainers to document topics and dates in Annexure-1: Training Record Sheet.

5.3 Hands-On Assessment

  1. Assign each trainee a supervised bioreactor operation simulation.
  2. Trainer evaluates:
    • SOP adherence
    • Equipment handling skill
    • Response to alarms and deviation scenarios
  3. Record results in Annexure-2: Practical Competency Checklist.
See also  Biosimilars: SOP for Primary Clarification Using Depth Filters in Bioreactor Operations - V 2.0

5.4 Qualification and Certification

  1. Only candidates scoring ≥85% in theory and passing practical are certified.
  2. Issue operator certification valid for 1 year (Annexure-3: Certificate Log).

5.5 Refresher Training

  1. Conduct annual refresher sessions or upon:
    • SOP revision
    • Recurrent deviations
    • Audit observation

5.6 Training Record Retention

  1. Retain training files for each operator for a minimum of 5 years.
  2. Ensure records are accessible for internal/external audits.

6. Abbreviations

  • SIP: Steam-In-Place
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. Training Record Sheet – Annexure-1
  2. Practical Competency Checklist – Annexure-2
  3. Certificate Log – Annexure-3

8. References

  • WHO TRS 1019 – GMP for Biological Products
  • ICH Q10 – Pharmaceutical Quality System
See also  Biosimilars: SOP for Deviation Handling in DSP - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Training Record Sheet

Date Module Trainer Trainee Signature
01/05/2025 Bioreactor Basics Ajay Verma Sunita Reddy Signed

Annexure-2: Practical Competency Checklist

Task Criteria Score Remarks
pH Calibration Correct SOP Use 10/10 Excellent

Annexure-3: Certificate Log

Trainee Name Certificate ID Date Issued Valid Until Issued By
Sunita Reddy BR-CERT-2025-011 04/05/2025 04/05/2026 Training Lead

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added annual certification policy and certificate log annexure Training compliance update
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Visual Inspection of Injectable Products for Clarity – V 2.0
Next Post: Gel Manufacturing: SOP for Secondary Packaging of Gel Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version